BRCA1 and ovarian neoplasm: Both BRCA1 and BRCA2 germline mutation-associated breast and ovarian tumors had a significantly lower proportion of the aging signature (Signatures 1 and 5) compared to nonBRCA breast and ovarian tumors (Supplementary Fig. 2c).